Pharmaceutical Industry
Global Pharmaceutical Companies Turn to Wolters Kluwer to Boost Research Automation & Efficiency
How sham patents are hurting the pharma industry
Novartis slammed for discrediting industry as ‘very concerned’ panel finds fault with Entresto files
Pharma gets ruthless as job losses mount across industry
The Indian pharma industry: Shaping a healthier world
Drug patents protect pharma profits. Track when they’ll expire here.
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
Pharma has over $500B in capital for deals
Drugs Licensed
5 Weight-Loss Drug Stocks To Watch
Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency
New York TikToker charged with selling Ozempic, other misbranded weight loss drugs that caused "significant, life-threatening injuries"
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
Woman Who Sold Misbranded Ozempic on TikTok Faces Smuggling Charge
Man charged in Monroe with illegally obtaining assortment of prescription drugs
Trucker acquitted in deadly crash asks for license back, but state says he contributed to accident
Man accused of dealing drugs outside gym in Flagler County
On I-95, speed, drugs and a special effort to stop them
Drugs Patents
The FTC is challenging 'junk' drug patents. Here's what they are and why they matter
Drug Patents and their Evergreening Conundrum
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Drug patents protect pharma profits. Track when they’ll expire here.
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
FTC cracking down on junk patents in drugs like Ozempic
FTC disputes new slate of Orange Book patents for weight loss, diabetes, asthma, and COPD drugs
Drugs Generics
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
Long Grove gets FDA OK for generic Radicava
Global generic drugs market to reach $671.5B by 2030, report finds
The FTC is challenging 'junk' drug patents. Here's what they are and why they matter
Senators float Medicare program that would offer incentive payments to combat drug shortages
Generics Player Teva Pharmaceutical Aces Late-Stage Schizophrenia Drug Study, Stock Shoots Higher
Can EU wean itself off essential drugs from China, India?
Scant drug ingredients linked to US generic-drug shortages in first 2 COVID years
New Jersey drug company to provide cash, naloxone to Delaware in latest opioid settlement
FDA Food and Drug Administration
US FDA advises healthcare facilities to switch from Getinge's heart devices
FDA recalls defective iOS app that injured over 200 insulin pump users
Pharmaceutical Companies
Global Pharmaceutical Companies Turn to Wolters Kluwer to Boost Research Automation & Efficiency
Canadian Pharma Stocks: 5 Biggest Companies in 2024
Pfizer to Settle 10K Lawsuits Over Drug Linked to Cancer, Costing Company Millions
Novartis slammed for discrediting industry as ‘very concerned’ panel finds fault with Entresto files
Royalty Pharma Reports First Quarter 2024 Results
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
How sham patents are hurting the pharma industry
Teva Pharmaceutical Industries 1Q Revenue Tops Estimates on Generic Products Sales Boost
Drug patents protect pharma profits. Track when they’ll expire here.